Nav: Home

Studies examine availability of opioid-overdose antidote at pharmacies

November 13, 2018

Bottom Line: Two studies looked at the availability of naloxone, an antidote for opioid overdoses, from pharmacies in two states that have passed legislation to allow pharmacists to dispense the medication without a physician's prescription.

What: Having access to naloxone can reduce the risk of death from an opioid overdose. Legislation in California has allowed trained pharmacists to provide naloxone without a physician's prescription since 2016. In this study, an anonymous telephone survey of some California community pharmacies was conducted in 2018 with interviewers posing as potential customers who asked pharmacy staff if they could get naloxone without a prescription. Less than 25 percent of about 1,150 retail pharmacies said they were giving naloxone to patients without a physician prescription. Of the pharmacies providing the medication, only about 50 percent had nasal naloxone in stock. Limitations of the study include a lack of data on the reasons why pharmacies weren't providing the naloxone.

Authors: Talia Puzantian, Pharm.D., BCPP, Keck Graduate Institute School of Pharmacy and Health Sciences, Claremont, California, and James J. Gasper, Pharm.D., BCPP, University of California, San Francisco

(doi:10.1001/jama.2018.12291)

What: A second study evaluated naloxone accessibility from chain pharmacies in Texas under a standing order from prescribers almost three years after Texas enacted legislation. Under a standing order, prescribers may authorize pharmacists to dispense naloxone without a prescription. In this study, interviewers posed as customers and spoke to pharmacists about wanting to purchase naloxone to have on hand in the event they had to respond to an opioid overdose. Among about 2,300 pharmacies, 84 percent indicated they would dispense the naloxone and 69 percent of pharmacies had the medication in stock. The study was limited by interviewing only one pharmacist per pharmacy and including only Texas chain pharmacies.

Authors: Kirk E. Evoy, Pharm.D., BCACP, BC-ADM, CTTS, the University of Texas at Austin, and coauthors

(doi:10.1001/jama.2018.15892)

Related Material: The editorial, "Overcoming Inertia to Improve Medication Use and Deprescribing," by Michael A. Steinman, M.D., University of California San Francisco, California, and C. Seth Landefeld, M.D., University of Alabama at Birmingham, is available on the For The Media website.
-end-
To Learn More: The full studies are available on the For The Media website.

Editor's Note:  Please see the articles for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Want to embed a link to these studies in your story? Links will be live at the embargo time

Puzantian study: http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.12291

Evoy study: http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.15892

JAMA

Related Medication Articles:

Kids diagnosed with ADHD often don't take medication regularly
Children diagnosed with ADHD inconsistently take their prescribed medication, going without treatment 40 per cent of the time, a new study has found.
Long-term medication for schizophrenia is safe
Researchers at Karolinska Institutet in Sweden and their colleagues in Germany, the USA and Finland have studied the safety of very long-term antipsychotic therapy for schizophrenia.
Which is more effective for treating PTSD: Medication, or psychotherapy?
A systematic review and meta-analysis led by Jeffrey Sonis, MD, MPH, of the University of North Carolina School of Medicine, finds there is insufficient evidence at present to answer that question.
ADHD medication: How much is too much for a hyperactive child?
When children with ADHD don't respond well to Methylphenidate (MPH, also known as Ritalin) doctors often increase the dose.
Pain medication use by children after common surgeries
About 400 caregivers reported pain medication use by children after common surgeries such as hernia, elbow fracture, appendectomy or adenoid removal in this study.
Bringing cancer medication safely to its destination
Treating cancer more selectively and more effectively -- this could be achieved with an innovative technology developed by teams of researchers at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and the Ludwig-Maximilians-Universität München (LMU).
Bullying linked to student's pain medication use
In a school-based survey study of all students in grades 6, 8, and 10 in Iceland, the use of pain medications was significantly higher among bullied students even when controlling for the amount of pain they felt, as well as age, gender, and socioeconomic status.
New medication gives mice bigger muscles
Researchers from Aarhus University, Denmark, have studied a new group of medicinal products which increase the muscle- and bone mass of mice over a few weeks.
Diabetes medication may protect against a common cause of blindness
Researchers from Taiwan have shown that people with type 2 diabetes who took a common diabetes medication, metformin, had a significantly lower rate of age-related macular degeneration (AMD).
Apps a timely reminder for those on heart medication
New research from the University of Sydney shows mobile apps could potentially save lives by helping people with coronary heart disease keep on top of their medication.
More Medication News and Medication Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.